Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 230

1.

Total compared with partial pancreatectomy for pancreatic adenocarcinoma: assessment of resection margin, readmission rate, and survival from the U.S. National Cancer Database.

Passeri MJ, Baker EH, Siddiqui IA, Templin MA, Martinie JB, Vrochides D, Iannitti DA.

Curr Oncol. 2019 Jun;26(3):e346-e356. doi: 10.3747/co.26.4066. Epub 2019 Jun 1.

2.

Efficacy of a Laparoscopic Saline-Coupled Bipolar Sealer in Minimally Invasive Hepatobiliary Surgery.

Sastry A, Sulzer JK, Passeri M, Baker EH, Vrochides D, McKillop IH, Iannitti DA, Martinie JB.

Surg Innov. 2019 Dec;26(6):668-674. doi: 10.1177/1553350619855282. Epub 2019 Jun 19.

PMID:
31215345
3.

Experimental High-Frequency Irreversible Electroporation Using a Single-Needle Delivery Approach for Nonthermal Pancreatic Ablation In Vivo.

O'Brien TJ, Passeri M, Lorenzo MF, Sulzer JK, Lyman WB, Swet JH, Vrochides D, Baker EH, Iannitti DA, Davalos RV, McKillop IH.

J Vasc Interv Radiol. 2019 Jun;30(6):854-862.e7. doi: 10.1016/j.jvir.2019.01.032.

PMID:
31126597
4.

Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons.

Sánchez-Velázquez P, Muller X, Malleo G, Park JS, Hwang HK, Napoli N, Javed AA, Inoue Y, Beghdadi N, Kalisvaart M, Vigia E, Walsh CD, Lovasik B, Busquets J, Scandavini C, Robin F, Yoshitomi H, Mackay TM, Busch OR, Hartog H, Heinrich S, Gleisner A, Perinel J, Passeri M, Lluis N, Raptis DA, Tschuor C, Oberkofler CE, DeOliveira ML, Petrowsky H, Martinie J, Asbun H, Adham M, Schulick R, Lang H, Koerkamp BG, Besselink MG, Han HS, Miyazaki M, Ferrone CR, Fernández-Del Castillo C, Lillemoe KD, Sulpice L, Boudjema K, Del Chiaro M, Fabregat J, Kooby DA, Allen P, Lavu H, Yeo CJ, Barroso E, Roberts K, Muiesan P, Sauvanet A, Saiura A, Wolfgang CL, Cameron JL, Boggi U, Yoon DS, Bassi C, Puhan MA, Clavien PA.

Ann Surg. 2019 Aug;270(2):211-218. doi: 10.1097/SLA.0000000000003223.

PMID:
30829701
5.

Ex vivo liver resection coupled with associated liver partition and portal vein ligation: Combining existing techniques to achieve surgical resectability.

Baimas-George MR, Levi DM, Eskind LB, Kirks RC, Passeri M, Lessne M, Kardassis D, Salmon S, Iannitti DA, Vrochides D.

J Surg Oncol. 2019 May;119(6):771-776. doi: 10.1002/jso.25375. Epub 2019 Jan 15.

PMID:
30644109
6.

Robotic-assisted versus laparoscopic left pancreatectomy at a high-volume, minimally invasive center.

Lyman WB, Passeri M, Sastry A, Cochran A, Iannitti DA, Vrochides D, Baker EH, Martinie JB.

Surg Endosc. 2019 Sep;33(9):2991-3000. doi: 10.1007/s00464-018-6565-6. Epub 2018 Nov 12.

PMID:
30421076
7.

Discrepancy in Postoperative Outcomes between Auditing Databases: A NSQIP Comparison.

Lyman WB, Passeri M, Cochran A, Iannitti DA, Martinie JB, Baker EH, Vrochides D.

Am Surg. 2018 Aug 1;84(8):1294-1298.

PMID:
30185303
8.

Current State of Enhanced Recovery After Surgery in Hepatopancreatobiliary Surgery.

Buhrman WC, Lyman WB, Kirks RC, Passeri M, Vrochides D.

J Laparoendosc Adv Surg Tech A. 2018 Dec;28(12):1471-1475. doi: 10.1089/lap.2018.0314. Epub 2018 Jun 20.

PMID:
29924662
9.

Outcomes of octogenarians undergoing gastrectomy performed for malignancy.

Teng A, Bellini G, Pettke E, Passeri M, Lee DY, Rose K, Bilchik AJ, Attiyeh F.

J Surg Res. 2017 Jan;207:1-6. doi: 10.1016/j.jss.2016.08.020. Epub 2016 Aug 12.

PMID:
27979463
10.

The identification of risk factors for venous thromboembolism in gastrointestinal oncologic surgery.

Bellini G, Teng A, Kotecha N, Sutton E, Yang CK, Passeri M, Lee DY, Rose K.

J Surg Res. 2016 Oct;205(2):279-285. doi: 10.1016/j.jss.2016.06.089. Epub 2016 Jul 4.

PMID:
27664873
11.

Drug-resistant tuberculosis in Central Mozambique: the role of a rapid genotypic susceptibility testing.

Namburete EI, Tivane I, Lisboa M, Passeri M, Pocente R, Ferro JJ, Harrison LH, Bollela VR.

BMC Infect Dis. 2016 Aug 17;16:423. doi: 10.1186/s12879-016-1766-x.

12.

Characterization of endocrine features and genotype-phenotypes correlations in blepharophimosis-ptosis-epicanthus inversus syndrome type 1.

Nuovo S, Passeri M, Di Benedetto E, Calanchini M, Meldolesi I, Di Giacomo MC, Petruzzi D, Piemontese MR, Zelante L, Sangiuolo F, Novelli G, Fabbri A, Brancati F.

J Endocrinol Invest. 2016 Feb;39(2):227-33. doi: 10.1007/s40618-015-0334-3. Epub 2015 Jun 23.

PMID:
26100530
13.

Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes.

Bianchi A, Valentini F, Iuorio R, Poggi M, Baldelli R, Passeri M, Giampietro A, Tartaglione L, Chiloiro S, Appetecchia M, Gargiulo P, Fabbri A, Toscano V, Pontecorvi A, De Marinis L.

J Exp Clin Cancer Res. 2013 Jun 21;32:40. doi: 10.1186/1756-9966-32-40.

14.

Hypogonadism in a patient with two novel mutations of the luteinizing hormone β-subunit gene expressed in a compound heterozygous form.

Basciani S, Watanabe M, Mariani S, Passeri M, Persichetti A, Fiore D, Scotto d'Abusco A, Caprio M, Lenzi A, Fabbri A, Gnessi L.

J Clin Endocrinol Metab. 2012 Sep;97(9):3031-8. doi: 10.1210/jc.2012-1986. Epub 2012 Jun 21.

PMID:
22723313
15.

Drinks like a fish: using zebrafish to understand alcoholic liver disease.

Howarth DL, Passeri M, Sadler KC.

Alcohol Clin Exp Res. 2011 May;35(5):826-9. doi: 10.1111/j.1530-0277.2010.01407.x. Epub 2011 Feb 1. Review.

16.

Hepatic steatosis in response to acute alcohol exposure in zebrafish requires sterol regulatory element binding protein activation.

Passeri MJ, Cinaroglu A, Gao C, Sadler KC.

Hepatology. 2009 Feb;49(2):443-52. doi: 10.1002/hep.22667.

17.

Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells.

Dejosez M, Krumenacker JS, Zitur LJ, Passeri M, Chu LF, Songyang Z, Thomson JA, Zwaka TP.

Cell. 2008 Jun 27;133(7):1162-74. doi: 10.1016/j.cell.2008.05.047. Erratum in: Cell. 2008 Aug 22;134(4):692.

18.

Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules.

Mercier GT, Nehete PN, Passeri MF, Nehete BN, Weaver EA, Templeton NS, Schluns K, Buchl SS, Sastry KJ, Barry MA.

Vaccine. 2007 Dec 17;25(52):8687-701. Epub 2007 Nov 5.

19.

The immune system in extreme longevity.

Sansoni P, Vescovini R, Fagnoni F, Biasini C, Zanni F, Zanlari L, Telera A, Lucchini G, Passeri G, Monti D, Franceschi C, Passeri M.

Exp Gerontol. 2008 Feb;43(2):61-5. Epub 2007 Jul 4. Review.

PMID:
17870272
20.

Calcium metabolism and vitamin D in the extreme longevity.

Passeri G, Vescovini R, Sansoni P, Galli C, Franceschi C, Passeri M; Italian Multicentric Study on Centenarians (IMUSCE).

Exp Gerontol. 2008 Feb;43(2):79-87. Epub 2007 Jul 4. Review.

21.

New insights into the biological and clinical significance of fecal calprotectin in inflammatory bowel disease.

Amati L, Passeri ME, Selicato F, Mastronardi ML, Penna A, Jirillo E, Covelli V.

Immunopharmacol Immunotoxicol. 2006;28(4):665-81.

PMID:
17190742
22.

Toll-like receptor signaling mechanisms involved in dendritic cell activation: potential therapeutic control of T cell polarization.

Amati L, Pepe M, Passeri ME, Mastronardi ML, Jirillo E, Covelli V.

Curr Pharm Des. 2006;12(32):4247-54. Review.

PMID:
17100626
23.

Osteoprotegerin and receptor activator of nuclear factor-kappa B ligand modulation by enamel matrix derivative in human alveolar osteoblasts.

Galli C, Macaluso GM, Guizzardi S, Vescovini R, Passeri M, Passeri G.

J Periodontol. 2006 Jul;77(7):1223-8.

PMID:
16805686
25.

Taking advantage of viral immune evasion: virus-derived proteins represent novel biopharmaceuticals.

Amati L, Passeri ME, Lippolis A, Lio D, Caruso C, Jirillo E, Covelli V.

Curr Med Chem. 2006;13(3):325-33. Review.

PMID:
16475940
26.

High risk for microcarcinoma in thyroid benign diseases. Incidence in a one year period of total thyroidectomies.

Carlini M, Giovannini C, Castaldi F, Mercadante E, Dell'Avanzato R, Zazza S, Nania A, Santeusanio G, Passeri M, Di Perna P.

J Exp Clin Cancer Res. 2005 Jun;24(2):231-6. Erratum in: J Exp Clin Cancer Res. 2007 Mar;26(1):2. Dell'Avanzato [corrected to Dell'Avanzato, R].

PMID:
16110756
27.

Drug targets in stress-related disorders.

Covelli V, Passeri ME, Leogrande D, Jirillo E, Amati L.

Curr Med Chem. 2005;12(15):1801-9. Review.

PMID:
16029148
28.

Rad23 as a reciprocal agent for stimulating or repressing immune responses.

Andersson HA, Passeri MF, Barry MA.

Hum Gene Ther. 2005 May;16(5):634-41.

PMID:
15916488
29.

Characteristics of adult patients with growth hormone deficiency who underwent neurosurgery for functioning and non-functioning pituitary adenomas and craniopharyngiomas.

Baldelli R, Bianchi A, Diacono F, Passeri M, Fusco A, Valle D, Poggi M, Terlini M, Toscano V, Tamburrano G, Pontecorvi A, Maira G, De Marinis L.

J Endocrinol Invest. 2005 Feb;28(2):157-61.

PMID:
15887862
30.

Low vitamin D status, high bone turnover, and bone fractures in centenarians.

Passeri G, Pini G, Troiano L, Vescovini R, Sansoni P, Passeri M, Gueresi P, Delsignore R, Pedrazzoni M, Franceschi C.

J Clin Endocrinol Metab. 2003 Nov;88(11):5109-15.

PMID:
14602735
31.

Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence.

Zanni F, Vescovini R, Biasini C, Fagnoni F, Zanlari L, Telera A, Di Pede P, Passeri G, Pedrazzoni M, Passeri M, Franceschi C, Sansoni P.

Exp Gerontol. 2003 Sep;38(9):981-7.

PMID:
12954485
32.

[Clinical surveillance of osteoporotic patients].

Passeri G, Passeri M.

Recenti Prog Med. 2003 May;94(5):211-6. Review. Italian.

PMID:
12723500
33.

Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes.

Giuliani N, Sansoni P, Girasole G, Vescovini R, Passeri G, Passeri M, Pedrazzoni M.

Exp Gerontol. 2001 Mar;36(3):547-57.

PMID:
11250125
34.

Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging.

Fagnoni FF, Vescovini R, Passeri G, Bologna G, Pedrazzoni M, Lavagetto G, Casti A, Franceschi C, Passeri M, Sansoni P.

Blood. 2000 May 1;95(9):2860-8.

PMID:
10779432
35.

Importance of bioavailable calcium drinking water for the maintenance of bone mass in post-menopausal women.

Costi D, Calcaterra PG, Iori N, Vourna S, Nappi G, Passeri M.

J Endocrinol Invest. 1999 Dec;22(11):852-6.

PMID:
10710273
36.

The role of calcitriol in the treatment of osteoporosis.

Nuti R, Bonucci E, Brancaccio D, Gallagher JC, Gennari C, Mazzuoli G, Passeri M, Sambrook P.

Calcif Tissue Int. 2000 Mar;66(3):239-40. Review. No abstract available.

PMID:
10666502
37.

Sleep disturbances in children with human immunodeficiency virus infection.

Franck LS, Johnson LM, Lee K, Hepner C, Lambert L, Passeri M, Manio E, Dorenbaum A, Wara D.

Pediatrics. 1999 Nov;104(5):e62.

PMID:
10545588
38.

[Perspectives in the treatment of osteoporosis].

Passeri M.

Recenti Prog Med. 1999 Sep;90(9):451-4. Review. Italian. No abstract available.

PMID:
10544665
39.

Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study.

Kanis J, Johnell O, Gullberg B, Allander E, Elffors L, Ranstam J, Dequeker J, Dilsen G, Gennari C, Vaz AL, Lyritis G, Mazzuoli G, Miravet L, Passeri M, Perez Cano R, Rapado A, Ribot C.

Osteoporos Int. 1999;9(1):45-54.

PMID:
10367029
40.

Declaration of Yuste. European Working Party.

Lye M, Vega Vega JL, Macías Nuñez JF, Millard P, Vellas B, Moulias R, Passeri M, Steen B, Reis R, Fisher R, Kaplan R, Marín Larraín PP, Galinsky D, Díaz Díaz AV, Vara GF, Ribera Casado JM, Llera FG.

Age Ageing. 1999 Mar;28(2):236. No abstract available.

PMID:
10350427
41.

The possible role of hematin and Mössbauer effect in the inhibition of osteosarcoma cell proliferation.

Ortalli I, Pedrazzi G, Giuliani N, Cai SZ, Fano V, Ma W, Girasole G, Passeri M.

Anticancer Res. 1998 Nov-Dec;18(6A):4127-30.

PMID:
9891457
42.

Effect of ipriflavone--a synthetic derivative of natural isoflavones--on bone mass loss in the early years after menopause.

Gennari C, Agnusdei D, Crepaldi G, Isaia G, Mazzuoli G, Ortolani S, Bufalino L, Passeri M.

Menopause. 1998 Spring;5(1):9-15.

PMID:
9689189
43.

Immunosenescence.

Franceschi C, Passeri M, De Benedictis G, Motta L.

Aging (Milano). 1998 Apr;10(2):153-4. Review. No abstract available.

PMID:
9666206
44.

A double blind, placebo-controlled trial of ipriflavone for prevention of postmenopausal spinal bone loss.

Agnusdei D, Crepaldi G, Isaia G, Mazzuoli G, Ortolani S, Passeri M, Bufalino L, Gennari C.

Calcif Tissue Int. 1997 Aug;61(2):142-7.

PMID:
9236262
45.

T lymphocyte proliferative capability to defined stimuli and costimulatory CD28 pathway is not impaired in healthy centenarians.

Sansoni P, Fagnoni F, Vescovini R, Mazzola M, Brianti V, Bologna G, Nigro E, Lavagetto G, Cossarizza A, Monti D, Franceschi C, Passeri M.

Mech Ageing Dev. 1997 Jun;96(1-3):127-36.

PMID:
9223116
46.

Mechanism of action of human calcitonin gene-related peptide in rabbit heart and in human mammary arteries.

Raddino R, Pelà G, Manca C, Barbagallo M, D'Aloia A, Passeri M, Visioli O.

J Cardiovasc Pharmacol. 1997 Apr;29(4):463-70.

PMID:
9156355
47.

Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass.

Gennari C, Adami S, Agnusdei D, Bufalíno L, Cervetti R, Crepaldi G, Di Marco C, Di Munno O, Fantasia L, Isaia GC, Mazzuoli GF, Ortolani S, Passeri M, Serni U, Vecchiet L.

Calcif Tissue Int. 1997;61 Suppl 1:S19-22.

PMID:
9263612
48.

Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years.

Adami S, Bufalino L, Cervetti R, Di Marco C, Di Munno O, Fantasia L, Isaia GC, Serni U, Vecchiet L, Passeri M.

Osteoporos Int. 1997;7(2):119-25.

PMID:
9166391
49.

[Involutional osteoporosis. Reflections on the problem].

Passeri M, Passeri G.

Recenti Prog Med. 1996 Dec;87(12):600-8. Review. Italian. No abstract available.

PMID:
9102701
50.

Supplemental Content

Loading ...
Support Center